Surgery Partners Inc
NASDAQ:SGRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Surgery Partners Inc
NASDAQ:SGRY
|
US |
|
H
|
H World Group Ltd
BMV:HTHTN
|
CN |
|
DHT Holdings Inc
NYSE:DHT
|
BM |
|
Macquarie Group Ltd
ASX:MQG
|
AU |
|
Tesla Inc
NASDAQ:TSLA
|
US |
|
Premia Finance SpA Societa di Mediazione Creditizia
MIL:PFI
|
IT |
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
|
Compagnie de Saint Gobain SA
PAR:SGO
|
FR |
|
Swiss Re AG
SIX:SREN
|
CH |
|
Tegna Inc
NYSE:TGNA
|
US |
|
China Telecom Corp Ltd
SSE:601728
|
CN |
|
Haitong Securities Co Ltd
SSE:600837
|
CN |
|
Bilibili Inc
NASDAQ:BILI
|
CN |
|
Unipol Gruppo SpA
MIL:UNI
|
IT |
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
Apogee Enterprises Inc
NASDAQ:APOG
|
US |
|
B
|
Bank Of Princeton
NASDAQ:BPRN
|
US |
|
Avis Budget Group Inc
NASDAQ:CAR
|
US |
|
Old Second Bancorp Inc
NASDAQ:OSBC
|
US |
|
Logitech International SA
SIX:LOGN
|
CH |
|
Kinross Gold Corp
TSX:K
|
CA |
|
Werner Enterprises Inc
NASDAQ:WERN
|
US |
|
Aya Gold & Silver Inc
TSX:AYA
|
CA |
Wall St Price Targets
SGRY Price Targets Summary
Surgery Partners Inc
According to Wall Street analysts, the average 1-year price target for SGRY is 19.53 USD with a low forecast of 14.14 USD and a high forecast of 26.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SGRY's stock price target?
Price Target
19.53
USD
According to Wall Street analysts, the average 1-year price target for SGRY is 19.53 USD with a low forecast of 14.14 USD and a high forecast of 26.25 USD.
What is the Revenue forecast for Surgery Partners Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 4 years is 9%.
What is the Operating Income forecast for Surgery Partners Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 3 years is -2%.
